Trials / Terminated
TerminatedNCT03247023
Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 61 (actual)
- Sponsor
- Smith & Nephew, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the long term performance and safety data for the Cadence™ Total Ankle System (CTAS) when used for primary arthroplasty in patients with primary arthritis (e.g. degenerative disease), secondary arthritis (e.g. post-traumatic, avascular necrosis, if minimally 2/3 of the talus is preserved), and systemic arthritis of the ankle (e.g. rheumatoid arthritis, hemochromatosis)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantation of Integra Cadence Total Ankle Sysyem | Primary Ankle Arthroplasty |
Timeline
- Start date
- 2017-09-18
- Primary completion
- 2021-12-08
- Completion
- 2023-09-06
- First posted
- 2017-08-11
- Last updated
- 2025-09-04
Locations
6 sites across 5 countries: Belgium, Canada, France, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT03247023. Inclusion in this directory is not an endorsement.